Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: pitfalls in neurooncology

…, F Spagnolli, G Frezza, M Leonardi, F Calbucci… - Neuro …, 2008 - academic.oup.com
Although radionecrosis has been exhaustively described in depth in the neurooncological
literature, its diagnosis is still a challenging issue because its radiological pattern is …

Cavernous malformations of the central nervous system in the pediatric age group

…, G Palandri, F Badaloni, M Zucchelli, F Calbucci - Pediatric …, 2009 - karger.com
Objective: The main clinico-diagnostic features, risk factors and associated diseases of
cavernous malformations (CMs), also called cavernous angiomas or cavernomas, of the …

[HTML][HTML] 106th Congress of the Italian Society of Otorhinolaryngology Head and Neck Surgery Official report: Surgery of the lateral skull base: a 50-year endeavour

…, D Borsetto, R Bovo, M Breun, F Calbucci… - Acta …, 2019 - ncbi.nlm.nih.gov
Disregarding the widely used division of skull base into anterior and lateral, since the skull
base should be conceived as a single anatomic structure, it was to our convenience to group …

[PDF][PDF] MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed …

…, R Bertorelle, S Bartolini, F Calbucci… - Journal of Clinical …, 2008 - academia.edu
Purpose Standard therapy for glioblastoma (GBM) is temozolomide (TMZ) administration,
initially concurrent with radiotherapy (RT), and subsequently as maintenance therapy. The …

The endoscopic extended transsphenoidal approach for craniopharyngiomas

…, V Sciarretta, G Farneti, F Calbucci - Operative …, 2006 - journals.lww.com
OBJECTIVE: The endoscope has recently been applied to the supradiaphragmatic
transsphenoidal approach, but only case reports dealing with different pathological features …

Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status

…, A Bacci, R Agati, F Calbucci… - … Journal of the …, 2009 - Wiley Online Library
BACKGROUND: A recent randomized study conducted on newly diagnosed glioblastoma
(GBM) patients demonstrated that concomitant and adjuvant temozolomide added to …

The endoscopic transnasal transsphenoidal approach for the treatment of cranial base chordomas and chondrosarcomas

G Frank, V Sciarretta, F Calbucci, G Farneti… - Operative …, 2006 - journals.lww.com
OBJECTIVE: We report our experience with endoscopic transsphenoidal or extended
endoscopic transsphenoidal approaches for the treatment of cranial base lesions such as …

Seizure outcome of epilepsy surgery in focal epilepsies associated with temporomesial glioneuronal tumors: lesionectomy compared with tailored resection

…, P Tinuper, L Castana, I Sartori, F Calbucci - Journal of …, 2009 - thejns.org
Object The authors retrospectively analyzed and compared seizure outcome in a series of
28 patients with temporomesial glioneuronal tumors associated with epilepsy who …

O6-methylguanine DNA-methyltransferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence …

…, M Gardiman, A Andreoli, F Calbucci… - Neuro …, 2010 - academic.oup.com
Abstract O 6-methylguanine DNA-methyltransferase (MGMT) promoter methylation status is
a prognostic factor in newly diagnosed glioblastoma patients. However, it is not yet clear …

Risk factors for the syndrome of ventricular enlargement with gait apraxia (idiopathic normal pressure hydrocephalus): a case-control study.

…, FM Cacciatore, R Daidone, F Calbucci… - Journal of Neurology …, 1989 - jnnp.bmj.com
A case-control study was performed to verify the association between the risk factors for
cerebrovascular disease and the syndrome of ventricular enlargement with gait apraxia …